(1) The CEO must conduct periodic reviews of cost - recovery arrangements in relation to the operations of NOPSEMA.
(2) A review under subsection (1) must include a comparison of the costs and expenses incurred by NOPSEMA in undertaking regulatory activities during the period covered by the review with the fees and levies collected by NOPSEMA that relate to that period.